Episode 40
Biotech Hangout
00:00
ASCO Plenary Session on Oncology
The big, it will now come down to the actual big data reel, which we know will take place on December 20th. There's going to be an ASCO plenary session and we will finally see the data. And I think expectations are still pretty positive here because Gilead did buy into the project. As far as Ash is concerned, I'm going to give you a few general thoughts without taking up too much time. The cell therapy focus at Ash will be a little bit muted again. Instead, we're going to see a lot more on bi-specific T-cell engages, that kind of thing. Tune in then for all the big themes of Ash.
Transcript
Play full episode
